PD-L1, which is constitutively expressed on the surface of tumor cells, is known to bind to PD-1 on T cells, thereby aberrantly activating certain downstream oncogenic signaling pathways and ultimately impairing the antitumor function of T cells (21). Here, CD274 is linked to neoplasm.